Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

CytRx initiates new phase II trial of purified RheothRx

May 5, 1997

Lp-PLA2 inhibitors from SmithKline Beecham

May 5, 1997

Zeneca and the University of Oxford enter collaboration for genetic research into heart disease

May 2, 1997

Calcium antagonist shown to cause left ventricular hypertrophy regression

April 30, 1997

Roche discloses human renin inhibitors

April 30, 1997

Kissei prepares smooth muscle cell proliferation inhibitors

April 30, 1997

Novel cardiac antiischemic agents disclosed by Kanebo

April 30, 1997

Endothelin antagonists reported by Kowa

April 30, 1997

Neurex's blood pressure treatment up for FDA advisory panel review in June

April 29, 1997

NOS inhibitors disclosed by Searle

April 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...